This indicates that the concurrent elevation of IL-6 and TNF-α should be highly suspected of depression, while meanwhile, reminding the clinical staff to carefully observe and timely formulate innovative therapeutic strategies. The gene discussed is IL6; the disease is major depressive disorder.